Alzamend Neuro Statistics
NASDAQ: ALZNHealthcareBiotechnologyUSD
1.34-0.03 (-2.19%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Alzamend Neuro by the numbers
Alzamend Neuro has a market capitalization of $6.5 million based on 4.83M shares outstanding. With trailing EPS of $-2.22, Alzamend Neuro is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 16.3% below its 50-day average and 13.3% below its 200-day average.
Average daily trading volume is 88.67K shares, or about $118,811 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ALZN valuation vs. peer median
| Metric | ALZN | Peer median | Difference |
|---|---|---|---|
| Market cap | $6.47M | $6.54M | -1% |
| Avg. volume | 88.67K | 271.65K | -67% |
Peer median across 8 companies: CELZ, XCUR, EVGN, LEXX, NRSN, ENVB, CANF, IMNN.
Valuation
- Market cap
- $6.47M
- EPS (TTM)
- $-2.22
- Shares outstanding
- 4.83M
Price and trading
- Previous close
- 1.37
- Open
- 1.32
- Day range
- 1.23 – 1.34
- 52-week range
- 0.84 – 2.68
- Beta
- —
- Volume
- 6.96K
- Average volume
- 88.67K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Jul 28, 2025
Additional statistics
- Market Cap
- 6.47M
- Forward Pe
- -1.54
- Eps
- -2.22
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.68
- Week52 Low
- 0.84
- Avg Volume
- 88,665.00
- Shares Outstanding
- 4.83M
- Ma50
- 1.60
- Ma200
- 1.55
- Earnings Date
- Jul 28, 2025
- Pct From52w High
- -50.00%
- Pct From52w Low
- 59.52%